# GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans

> **NCT02731664** · PHASE1 · COMPLETED · sponsor: **Uppsala University** · enrollment: 12 (actual)

## Conditions studied

- Functional Gastrointestinal Disorders

## Interventions

- **BIOLOGICAL:** GLP-1
- **BIOLOGICAL:** Intravenous saline

## Key facts

- **NCT ID:** NCT02731664
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02731664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02731664, "GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02731664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*